UK Funding for Forxiga Inches CloserUK Funding for Forxiga Inches Closer
The UK body NICE has issued draft guidance saying it will likely fund the new SGLT-2 inhibitor dapagliflozin for some patients with type 2 diabetes, in combination with metformin or insulin. WebMD Health News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Forxiga | Funding | Health | Insulin | Metformin | National Institute for Health and Clinical Excelle